ARS Pharmaceuticals Inc. (SPRY)
11.53
0.17 (1.50%)
At close: Jan 15, 2025, 12:31 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 70.97M | 210.52M | 60.06M | 24.52M | 9.98M | 20.16M |
| Short-Term Investments | 157.39M | 63.86M | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 64.78M | 350.00K | 550.00K | 750.00K |
| Other Long-Term Assets | 21.00K | 2.96M | -64.76M | -348.00K | n/a | n/a |
| Receivables | 795.00K | n/a | 1K | 384.00K | n/a | n/a |
| Inventory | n/a | -1.01M | -6.78M | -2.61M | n/a | n/a |
| Other Current Assets | 2.57M | 2.31M | 666.00K | 1.48M | 552.00K | 618.00K |
| Total Current Assets | 231.73M | 277.70M | 60.73M | 26.38M | 10.53M | 20.78M |
| Property-Plant & Equipment | 824.00K | 774.00K | 693.00K | 23.00K | 4.57M | 6.02M |
| Goodwill & Intangibles | 617.00K | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.46M | 3.73M | 716.00K | 25.00K | 5.12M | 6.77M |
| Total Assets | 233.19M | 281.44M | 61.45M | 26.41M | 15.65M | 27.55M |
| Account Payables | 759.00K | 1.66M | 1.79M | 1.22M | 3.52M | 775.00K |
| Deferred Revenue | n/a | 283.00K | 1.46M | 3.52M | n/a | n/a |
| Short-Term Debt | 237.00K | 460.00K | 3.62M | 2.56M | 12.30M | 3.53M |
| Other Current Liabilities | 1.39M | 2.87M | 1.32M | 915.00K | 2.11M | 841.00K |
| Total Current Liabilities | 2.39M | 5.44M | 8.19M | 8.21M | 17.93M | 5.14M |
| Long-Term Debt | 37.00K | 251.00K | 5.41M | 7.46M | 3.32M | 4.21M |
| Other Long-Term Liabilities | n/a | n/a | 76.12M | 27.00K | n/a | -1 |
| Total Long-Term Liabilities | 37.00K | 3.10M | 84.53M | 32.25M | 3.32M | 4.21M |
| Total Liabilities | 2.43M | 8.55M | 92.72M | 40.46M | 21.25M | 9.35M |
| Total Debt | 274.00K | 481.00K | 9.03M | 10.02M | 15.62M | 7.73M |
| Common Stock | 10.00K | 9.00K | 257.00K | 223.00K | n/a | n/a |
| Retained Earnings | -131.30M | -76.94M | -42.26M | -22.01M | -63.79M | -39.82M |
| Comprehensive Income | 49.00K | 407.00K | -326.00K | -21.23M | n/a | n/a |
| Shareholders Equity | 230.76M | 272.89M | -31.27M | -14.05M | -5.60M | 18.20M |
| Total Investments | 157.39M | 63.86M | 64.78M | 350.00K | 550.00K | 750.00K |